Ophthalmic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Report
138 Pages
June 2023
Region: Global
IMARC Group
ID: 5834446

The global ophthalmic drugs market size reached US$ 42.8 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 59.1 Billion by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2023-2028.

Ophthalmic drugs are medications that are specially designed and administered for the treatment of various eye-related disorders, including color blindness, diabetic macular edema, cytomegalovirus (CMV), and age-related macular degeneration (AMD). These medications can be delivered in the form of an emulsion, ointment, aqueous gels, dendrimers, nanosuspensions, or contact lenses. Ophthalmic drugs are manufactured from neomycin, antibiotics, bacitracin, and polymyxin that aid in mitigating the growth of bacterial infection in the eye. At present, they are commercially available in solid, liquid, and semi-solid formulation types.

Ophthalmic Drugs Market Trends:

The increasing prevalence of various eye-related disorders, such as visual impairment, glaucoma, and color blindness, especially amongst the rising geriatric population, is primarily driving the ophthalmic drugs market growth. In line with this, the rising awareness regarding the anti-inflammatory properties of the drug is further facilitating their demand to treat scleritis, cystoid macular edema, and uveitis disorders. Moreover, the extensive fundings and favorable initiatives being undertaken by the governments of several countries to promote the production of effective ophthalmic drugs with novel formulations and combinations are also supporting the market growth. Besides this, significant technological advancements, including the introduction of gene-drug therapies for diagnosing and treating hereditary ophthalmic, neurovascular retinal, and retinoblastoma disorders, are acting as another growth-inducing factors. Additionally, the easy availability of ophthalmic drugs in eye solutions, drops, capsules, tablets, gels, and ointments forms across several online and offline distribution channels is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, along with rising research and development (R&D) activities to introduce cost-effective ocular drug delivery systems (ODDS), are creating a positive outlook for the market.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global ophthalmic drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, drug class, indication, dosage form and distribution channel.

Breakup by Type:

Prescription Drugs
Over-the-counter Drugs

Breakup by Drug Class:

Anti-glaucoma
Anti-infection
Anti-inflammation
Anti-allergy
Others

Breakup by Indication:

Dry Eye
Glaucoma
Infection/Inflammation/Allergy
Retinal Disorders
Others

Breakup by Dosage Form:

Liquid Ophthalmic Drug Forms
Solid Ophthalmic Drug Forms
Semisolid Ophthalmic Drug Forms
Multicompartment Drug Delivery Systems
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Drug Stores
Online Pharmacies
Others

Breakup by Region:

North America

United States
Canada

Asia-Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others

Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others

Latin America

Brazil
Mexico
Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Aerie Pharmaceuticals Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Sun Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:

How has the global ophthalmic drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global ophthalmic drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the dosage form?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global ophthalmic drugs market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Ophthalmic Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Prescription Drugs
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over-the-counter Drugs
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Drug Class

7.1 Anti-glaucoma
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anti-infection
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Anti-inflammation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-allergy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Indication

8.1 Dry Eye
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Glaucoma
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infection/Inflammation/Allergy
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Retinal Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Dosage Form

9.1 Liquid Ophthalmic Drug Forms
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Solid Ophthalmic Drug Forms
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Semisolid Ophthalmic Drug Forms
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Multicompartment Drug Delivery Systems
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by Distribution Channel

10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Drug Stores
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast

11 Market Breakup by Region

11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Aerie Pharmaceuticals Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3 Akorn Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 Alcon
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 Bausch Health Companies Inc.
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Bayer AG
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 F. Hoffmann-La Roche AG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 SWOT Analysis
16.3.8 Johnson & Johnson
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Merck & Co. Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Novartis AG
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Regeneron Pharmaceuticals Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Santen Pharmaceutical Co. Ltd.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.13 Sun Pharmaceutical Industries Ltd.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio

List of Figures

Figure 1: Global: Ophthalmic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Ophthalmic Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Ophthalmic Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Ophthalmic Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Ophthalmic Drugs Market: Breakup by Drug Class (in %), 2022
Figure 6: Global: Ophthalmic Drugs Market: Breakup by Indication (in %), 2022
Figure 7: Global: Ophthalmic Drugs Market: Breakup by Dosage Form (in %), 2022
Figure 8: Global: Ophthalmic Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 9: Global: Ophthalmic Drugs Market: Breakup by Region (in %), 2022
Figure 10: Global: Ophthalmic Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Ophthalmic Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Ophthalmic Drugs (Anti-glaucoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Ophthalmic Drugs (Anti-glaucoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Ophthalmic Drugs (Anti-infection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Ophthalmic Drugs (Anti-infection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Ophthalmic Drugs (Anti-inflammation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Ophthalmic Drugs (Anti-inflammation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Ophthalmic Drugs (Anti-allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Ophthalmic Drugs (Anti-allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Ophthalmic Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Ophthalmic Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Ophthalmic Drugs (Dry Eye) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Ophthalmic Drugs (Dry Eye) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Ophthalmic Drugs (Glaucoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Ophthalmic Drugs (Glaucoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Ophthalmic Drugs (Retinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Ophthalmic Drugs (Retinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Ophthalmic Drugs (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Ophthalmic Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Ophthalmic Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Ophthalmic Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Ophthalmic Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Ophthalmic Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Ophthalmic Drugs (Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Ophthalmic Drugs (Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Ophthalmic Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Ophthalmic Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Global: Ophthalmic Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Global: Ophthalmic Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: North America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: North America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: United States: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: United States: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Canada: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Canada: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Asia-Pacific: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Asia-Pacific: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: China: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: China: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Japan: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Japan: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: India: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: India: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: South Korea: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: South Korea: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Australia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Australia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Indonesia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Indonesia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Europe: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Europe: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Germany: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Germany: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: France: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: France: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: United Kingdom: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: United Kingdom: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Italy: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Italy: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Spain: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Spain: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Russia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Russia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Latin America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Latin America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Brazil: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Brazil: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Mexico: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Mexico: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Middle East and Africa: Ophthalmic Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 99: Middle East and Africa: Ophthalmic Drugs Market: Breakup by Country (in %), 2022
Figure 100: Middle East and Africa: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 101: Global: Ophthalmic Drugs Industry: SWOT Analysis
Figure 102: Global: Ophthalmic Drugs Industry: Value Chain Analysis
Figure 103: Global: Ophthalmic Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Ophthalmic Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Ophthalmic Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Ophthalmic Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 4: Global: Ophthalmic Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 5: Global: Ophthalmic Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
Table 6: Global: Ophthalmic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 7: Global: Ophthalmic Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Ophthalmic Drugs Market: Competitive Structure
Table 9: Global: Ophthalmic Drugs Market: Key Players

Companies Mentioned

AbbVie Inc.
Aerie Pharmaceuticals Inc.
Akorn Inc.
Alcon
Bausch Health Companies Inc.
Bayer AG
F. Hoffmann-La Roche AG
Johnson & Johnson
Merck & Co. Inc.
Novartis AG
Regeneron Pharmaceuticals Inc.
Santen Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	138
Published	June 2023
Forecast Period	2022 - 2028
Estimated Market Value ( USD ) in 2022	$ 42.8 Billion
Forecasted Market Value ( USD ) by 2028	$ 59.1 Billion
Compound Annual Growth Rate	5.5%
Regions Covered	Global
No. of Companies Mentioned	13

PURCHASE OPTIONS

Single User License PDF

1 - 5 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2427EUR$2,499USD£2,074GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€3398EUR$3,499USD£2,903GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€4370EUR$4,499USD£3,733GBP